Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/13/2025

Drug Interactions with Dayvigo (Lemborexant)

Contraindicated Combinations

  • The American Heart Association recommends avoiding concomitant use of Dayvigo with moderate or strong CYP3A inhibitors, such as ketoconazole, clarithromycin, and protease inhibitors, as these interactions can significantly alter lemborexant exposure and lead to excessive sedation or loss of efficacy 1, 2
  • The American Association for the Study of Liver Diseases advises avoiding concomitant use of Dayvigo with strong CYP3A inducers, such as rifampin, carbamazepine, phenobarbital, phenytoin, and St. John's wort, as these interactions can render the medication ineffective 1, 2

Moderate-Risk Interactions Requiring Dose Adjustment

  • The American College of Chest Physicians recommends considering dose reduction of lemborexant when combining with P-gp inhibitors, such as amiodarone and verapamil, particularly in patients with renal impairment 3, 4, 5
  • The American Heart Association suggests that P-gp inhibitors, such as amiodarone and verapamil, may increase lemborexant exposure by 50-60% and 60-180%, respectively, similar to effects seen with dabigatran 3, 4

Special Population Considerations

  • The American Society of Nephrology recommends considering lower starting doses (5 mg) of lemborexant in patients with moderate to severe renal impairment taking interacting medications, as drug interactions are exacerbated in renal impairment 5
  • The American Association for the Study of Liver Diseases advises avoiding combining lemborexant with hepatotoxic medications, such as azole antifungals and certain antiretrovirals, in patients with liver disease, as lemborexant exposure increases 2.3-fold in moderate hepatic impairment 7

Clinical Monitoring Recommendations

  • The Journal of Hepatology recommends evaluating all concomitant medications before prescribing lemborexant, including over-the-counter drugs and herbal supplements, to assess potential drug interactions 2